[
    [
        {
            "time": "",
            "original_text": "华大基因：公司的安孕可单基因遗传病携带者筛查系列，可一次性检测10种/155种常见单基因遗传病致病变异的携带情况",
            "features": {
                "keywords": [
                    "华大基因",
                    "安孕可",
                    "单基因遗传病",
                    "携带者筛查",
                    "检测"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因：公司的安孕可单基因遗传病携带者筛查系列，可一次性检测10种/155种常见单基因遗传病致病变异的携带情况",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华大基因：已第一时间完成对Omicron的全部生物信息学分析，表明Omicron对华大基因新冠检测试剂盒的检测性能没有影响，检测准确性及灵敏度不会降低",
            "features": {
                "keywords": [
                    "华大基因",
                    "Omicron",
                    "新冠检测",
                    "试剂盒",
                    "生物信息学分析"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：已第一时间完成对Omicron的全部生物信息学分析，表明Omicron对华大基因新冠检测试剂盒的检测性能没有影响，检测准确性及灵敏度不会降低",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "干货！2022年中国基因测序行业龙头企业发展分析——迪安诊断：业务领域持续拓宽",
            "features": {
                "keywords": [
                    "基因测序",
                    "龙头",
                    "迪安诊断",
                    "业务领域",
                    "拓宽"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "干货！2022年中国基因测序行业龙头企业发展分析——迪安诊断：业务领域持续拓宽",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]